Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used ... Before Wegovy, 190,000 people in the U.S. were claiming GLP-1 drugs each month; by August 2024, this number ...
Viking Therapeutics’ GLP-1 pill candidate for treating obesity showed promise in its latest trial results, the clinical-stage biopharma announced Monday. In a study that tested the highest dosage of ...
Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo ...
Recently, REIT market suffered steeper declines than S&P 500, primarily due to rising long-term financing yields. Click here ...
Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback